Daisuke Kaneda

Years Active: 2020-2022
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Daisuke Kaneda, Tomoko Iehara, Ken Kikuchi, Yohei Sugimoto, Norio Nakagawa, Shigeki Yagyu, Mitsuru Miyachi, Eiichi Konishi, Toshiyuki Sakai, Hajime Hosoi
The histone deacetylase inhibitor OBP-801 has in vitro/in vivo anti-neuroblastoma activity. Pediatrics international : official journal of the Japan Pediatric Society 64 (1) (2022)
Yohei Sugimoto, Yoshiki Katsumi, Tomoko Iehara, Daisuke Kaneda, Chihiro Tomoyasu, Kazutaka Ouchi, Hideki Yoshida, Mitsuru Miyachi, Shigeki Yagyu, Ken Kikuchi, Kunihiko Tsuchiya, Yasumichi Kuwahara, Toshiyuki Sakai, Hajime Hosoi
The Novel Histone Deacetylase Inhibitor, OBP-801, Induces Apoptosis in Rhabdoid Tumors by Releasing the Silencing of NOXA. Molecular cancer therapeutics 19 (10) (2020)

Daisuke Kaneda.css-eqlu8i{font-size:small;padding-left:4px;}